Jinkai Biotechnology: The company currently does not have any products related to Lilly's weight-loss drug.

date
09/02/2026
On February 9th, Jinkaiseng Science stated on the interactive platform that the company currently does not have any products related to the Lialai weight loss drug. Patent protection for original research drug factories generally involves multiple mechanisms, including compound patents, formulation and composition patents, as well as medical use patents. The impact of the expiration of a single compound patent is currently difficult to accurately predict, and the company will continue to monitor relevant changes.